Evidence map›Paper›PMID 30027602›Full record

ReviewThe FEBS journal2019

Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications.

Aitor Almanza, Antonio Carlesso, Chetan Chintha, Stuart Creedican, Dimitrios Doultsinos, Brian Leuzzi, Andreia Luís, Nicole McCarthy, Luigi Montibeller, Sanket More and 15 more

Open access · hybridAbstract readReview
In one paragraph

Review in The FEBS journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 520 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
520citing papers in PubMed, 3 pooled it
36.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

520 citing papers in PubMed, 3 syntheses or guidelines pooled it, 976 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

460 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 8 countries.

Aitor AlmanzaApoptosis Research Centre, National University of Ireland, Galway, Ireland.
Antonio CarlessoDepartment of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
Chetan ChinthaApoptosis Research Centre, National University of Ireland, Galway, Ireland.
Stuart CreedicanRandox Teoranta, Dungloe, County Donegal, Ireland.
Dimitrios DoultsinosINSERM U1242, University of Rennes, France.
Brian LeuzziApoptosis Research Centre, National University of Ireland, Galway, Ireland.
Andreia LuísLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Nicole McCarthyInstitute for Experimental Cancer Research in Paediatrics, Goethe-University, Frankfurt, Germany.
Luigi MontibellerNeurogenetics Group, Division of Brain Sciences, Faculty of Medicine, Imperial College London, UK.
Sanket MoreDepartment Cellular and Molecular Medicine, Laboratory of Cell Death and Therapy, KU Leuven, Belgium.
Alexandra PapaioannouINSERM U1242, University of Rennes, France.
Franziska PüschelCell Death Regulation Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Maria Livia SassanoDepartment Cellular and Molecular Medicine, Laboratory of Cell Death and Therapy, KU Leuven, Belgium.
Josip SkokoInstitute of Cell Biology and Immunology, University of Stuttgart, Germany.
Patrizia AgostinisDepartment Cellular and Molecular Medicine, Laboratory of Cell Death and Therapy, KU Leuven, Belgium.
Jackie de BellerocheNeurogenetics Group, Division of Brain Sciences, Faculty of Medicine, Imperial College London, UK.
Leif A ErikssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Göteborg, Sweden.
Simone FuldaInstitute for Experimental Cancer Research in Paediatrics, Goethe-University, Frankfurt, Germany.
Adrienne M GormanApoptosis Research Centre, National University of Ireland, Galway, Ireland.ORCID 0000-0002-6068-0058
Sandra HealyApoptosis Research Centre, National University of Ireland, Galway, Ireland.
Andrey KozlovLudwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Centre, Vienna, Austria.
Cristina Muñoz-PinedoCell Death Regulation Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.ORCID 0000-0002-9120-664X
Markus RehmInstitute of Cell Biology and Immunology, University of Stuttgart, Germany.
Eric ChevetINSERM U1242, University of Rennes, France.ORCID 0000-0001-5855-4522
Afshin SamaliApoptosis Research Centre, National University of Ireland, Galway, Ireland.
Ollscoil na Gaillimhe – University of Galway · IEInserm · FRKU Leuven · BEGoethe University Frankfurt · DEImperial College London · GBInstitut d'Investigació Biomédica de Bellvitge · ESLudwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA · ATUniversity of Gothenburg · SEUniversity of Stuttgart · DEOGT Amenity (Ireland) · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The endoplasmic reticulum (ER) is a membranous intracellular organelle and the first compartment of the secretory pathway. As such, the ER contributes to the production and folding of approximately one-third of cellular proteins, and is thus inextricably linked to the maintenance of cellular homeostasis and the fine balance between health and disease. Specific ER stress signalling pathways, collectively known as the unfolded protein response (UPR), are required for maintaining ER homeostasis. The UPR is triggered when ER protein folding capacity is overwhelmed by cellular demand and the UPR initially aims to restore ER homeostasis and normal cellular functions. However, if this fails, then the UPR triggers cell death. In this review, we provide a UPR signalling-centric view of ER functions, from the ER's discovery to the latest advancements in the understanding of ER and UPR biology. Our review provides a synthesis of intracellular ER signalling revolving around proteostasis and the UPR, its impact on other organelles and cellular behaviour, its multifaceted and dynamic response to stress and its role in physiology, before finally exploring the potential exploitation of this knowledge to tackle unresolved biological questions and address unmet biomedical needs. Thus, we provide an integrated and global view of existing literature on ER signalling pathways and their use for therapeutic purposes.

Indexed as

Endoplasmic Reticulum StressUnfolded Protein ResponseAnimalsEndoplasmic ReticulumHomeostasisHumansSignal Transductionendoplasmic reticulumproteostasissignalling pathwaystress

Identifiers

PMID30027602
PMCPMC7379631
OpenAlexW2883231068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.